ArticleInternational journal of clinical oncology2022

Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients.

Naomi Iwasa-Inoue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.